vs

Side-by-side financial comparison of Madison Square Garden Sports Corp. (MSGS) and SelectQuote, Inc. (SLQT). Click either name above to swap in a different company.

SelectQuote, Inc. is the larger business by last-quarter revenue ($537.1M vs $403.4M, roughly 1.3× Madison Square Garden Sports Corp.). SelectQuote, Inc. runs the higher net margin — 12.9% vs 2.0%, a 10.9% gap on every dollar of revenue. On growth, Madison Square Garden Sports Corp. posted the faster year-over-year revenue change (12.8% vs 11.6%). Madison Square Garden Sports Corp. produced more free cash flow last quarter ($31.6M vs $-1.0M). Over the past eight quarters, SelectQuote, Inc.'s revenue compounded faster (19.5% CAGR vs -3.1%).

Madison Square Garden Sports Corp. is an American sports holding company based in New York City.

SelectQuote is a direct-to-consumer distribution platform for selling insurance policies and healthcare services. Their insurance business earns commissions by connecting consumers with insurance carriers that provide senior health, life, automobile, and home insurance. The healthcare services business mainly consists of SelectRx, an accredited pharmacy. The company went public on May 21, 2020.

MSGS vs SLQT — Head-to-Head

Bigger by revenue
SLQT
SLQT
1.3× larger
SLQT
$537.1M
$403.4M
MSGS
Growing faster (revenue YoY)
MSGS
MSGS
+1.1% gap
MSGS
12.8%
11.6%
SLQT
Higher net margin
SLQT
SLQT
10.9% more per $
SLQT
12.9%
2.0%
MSGS
More free cash flow
MSGS
MSGS
$32.6M more FCF
MSGS
$31.6M
$-1.0M
SLQT
Faster 2-yr revenue CAGR
SLQT
SLQT
Annualised
SLQT
19.5%
-3.1%
MSGS

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
MSGS
MSGS
SLQT
SLQT
Revenue
$403.4M
$537.1M
Net Profit
$8.2M
$69.3M
Gross Margin
61.8%
Operating Margin
5.5%
14.0%
Net Margin
2.0%
12.9%
Revenue YoY
12.8%
11.6%
Net Profit YoY
641.9%
30.2%
EPS (diluted)
$0.34
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSGS
MSGS
SLQT
SLQT
Q4 25
$403.4M
$537.1M
Q3 25
$39.5M
$328.8M
Q2 25
$204.0M
$345.1M
Q1 25
$424.2M
$408.2M
Q4 24
$357.8M
$481.1M
Q3 24
$53.3M
$292.3M
Q2 24
$227.3M
$307.2M
Q1 24
$430.0M
$376.4M
Net Profit
MSGS
MSGS
SLQT
SLQT
Q4 25
$8.2M
$69.3M
Q3 25
$-8.8M
$-30.5M
Q2 25
$-1.8M
$12.9M
Q1 25
$-14.2M
$26.0M
Q4 24
$1.1M
$53.2M
Q3 24
$-7.5M
$-44.5M
Q2 24
$25.5M
$-31.0M
Q1 24
$37.9M
$8.6M
Gross Margin
MSGS
MSGS
SLQT
SLQT
Q4 25
61.8%
Q3 25
41.4%
Q2 25
47.2%
Q1 25
60.2%
Q4 24
67.5%
Q3 24
55.7%
Q2 24
60.7%
Q1 24
71.8%
Operating Margin
MSGS
MSGS
SLQT
SLQT
Q4 25
5.5%
14.0%
Q3 25
-69.5%
-12.4%
Q2 25
-11.1%
-3.6%
Q1 25
7.6%
5.4%
Q4 24
3.7%
14.7%
Q3 24
-15.5%
-4.1%
Q2 24
23.0%
-0.5%
Q1 24
18.5%
8.8%
Net Margin
MSGS
MSGS
SLQT
SLQT
Q4 25
2.0%
12.9%
Q3 25
-22.3%
-9.3%
Q2 25
-0.9%
3.7%
Q1 25
-3.4%
6.4%
Q4 24
0.3%
11.1%
Q3 24
-14.1%
-15.2%
Q2 24
11.2%
-10.1%
Q1 24
8.8%
2.3%
EPS (diluted)
MSGS
MSGS
SLQT
SLQT
Q4 25
$0.34
$0.26
Q3 25
$-0.37
$-0.26
Q2 25
$-0.08
$-0.06
Q1 25
$-0.59
$0.03
Q4 24
$0.05
$0.30
Q3 24
$-0.31
$-0.26
Q2 24
$1.07
$-0.17
Q1 24
$1.57
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSGS
MSGS
SLQT
SLQT
Cash + ST InvestmentsLiquidity on hand
$81.3M
$18.3M
Total DebtLower is stronger
$405.8M
Stockholders' EquityBook value
$-282.1M
$359.7M
Total Assets
$1.5B
$1.4B
Debt / EquityLower = less leverage
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSGS
MSGS
SLQT
SLQT
Q4 25
$81.3M
$18.3M
Q3 25
$48.6M
$10.7M
Q2 25
$144.6M
$32.4M
Q1 25
$96.5M
$80.1M
Q4 24
$107.8M
$7.3M
Q3 24
$52.3M
$10.4M
Q2 24
$89.1M
$42.7M
Q1 24
$40.0M
$37.8M
Total Debt
MSGS
MSGS
SLQT
SLQT
Q4 25
$405.8M
Q3 25
$393.1M
Q2 25
$385.1M
Q1 25
$391.5M
Q4 24
$711.9M
Q3 24
$680.4M
Q2 24
$683.3M
Q1 24
$686.0M
Stockholders' Equity
MSGS
MSGS
SLQT
SLQT
Q4 25
$-282.1M
$359.7M
Q3 25
$-294.2M
$305.1M
Q2 25
$-281.4M
$351.1M
Q1 25
$-283.4M
$350.2M
Q4 24
$-273.1M
$326.0M
Q3 24
$-277.5M
$269.4M
Q2 24
$-266.3M
$316.8M
Q1 24
$-294.0M
$346.8M
Total Assets
MSGS
MSGS
SLQT
SLQT
Q4 25
$1.5B
$1.4B
Q3 25
$1.5B
$1.2B
Q2 25
$1.5B
$1.2B
Q1 25
$1.5B
$1.3B
Q4 24
$1.4B
$1.3B
Q3 24
$1.4B
$1.1B
Q2 24
$1.3B
$1.2B
Q1 24
$1.4B
$1.2B
Debt / Equity
MSGS
MSGS
SLQT
SLQT
Q4 25
1.13×
Q3 25
1.29×
Q2 25
1.10×
Q1 25
1.12×
Q4 24
2.18×
Q3 24
2.53×
Q2 24
2.16×
Q1 24
1.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSGS
MSGS
SLQT
SLQT
Operating Cash FlowLast quarter
$32.4M
$52.0K
Free Cash FlowOCF − Capex
$31.6M
$-1.0M
FCF MarginFCF / Revenue
7.8%
-0.2%
Capex IntensityCapex / Revenue
0.2%
0.2%
Cash ConversionOCF / Net Profit
3.94×
0.00×
TTM Free Cash FlowTrailing 4 quarters
$-480.0K
$8.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSGS
MSGS
SLQT
SLQT
Q4 25
$32.4M
$52.0K
Q3 25
$-85.0M
$-21.6M
Q2 25
$49.7M
$-37.5M
Q1 25
$6.3M
$71.1M
Q4 24
$61.8M
$-28.7M
Q3 24
$-26.2M
$-16.6M
Q2 24
$108.4M
$20.0M
Q1 24
$4.0M
$44.5M
Free Cash Flow
MSGS
MSGS
SLQT
SLQT
Q4 25
$31.6M
$-1.0M
Q3 25
$-85.3M
$-22.7M
Q2 25
$49.4M
$-38.0M
Q1 25
$3.9M
$70.2M
Q4 24
$61.2M
$-29.0M
Q3 24
$-26.5M
$-17.1M
Q2 24
$108.0M
$19.7M
Q1 24
$3.9M
$43.4M
FCF Margin
MSGS
MSGS
SLQT
SLQT
Q4 25
7.8%
-0.2%
Q3 25
-216.3%
-6.9%
Q2 25
24.2%
-11.0%
Q1 25
0.9%
17.2%
Q4 24
17.1%
-6.0%
Q3 24
-49.7%
-5.8%
Q2 24
47.5%
6.4%
Q1 24
0.9%
11.5%
Capex Intensity
MSGS
MSGS
SLQT
SLQT
Q4 25
0.2%
0.2%
Q3 25
0.9%
0.3%
Q2 25
0.2%
0.1%
Q1 25
0.6%
0.2%
Q4 24
0.1%
0.1%
Q3 24
0.7%
0.2%
Q2 24
0.2%
0.1%
Q1 24
0.0%
0.3%
Cash Conversion
MSGS
MSGS
SLQT
SLQT
Q4 25
3.94×
0.00×
Q3 25
Q2 25
-2.91×
Q1 25
2.73×
Q4 24
55.61×
-0.54×
Q3 24
Q2 24
4.25×
Q1 24
0.11×
5.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSGS
MSGS

Event Related$167.2M41%
Media Rights$122.3M30%
Sponsorship Signage And Suite Licenses$98.5M24%
League Distribution$15.4M4%

SLQT
SLQT

Healthcare Services Segment$230.7M43%
Pharmacy$227.2M42%
Other$30.4M6%
Final Expense$20.4M4%
Term$18.5M3%
Other Senior$6.3M1%
All Other Revenue$3.9M1%

Related Comparisons